Incidence and prognosis of early hepatic dysfunction in critically ill patients—A prospective multicenter study

Kramer, Ludwig; Jordan, Barbara; Druml, Wilfred; Bauer, Péter; Metnitz, Philipp

doi:10.1097/01.ccm.0000259462.97164.a0

Cited by 263 publications

(234 citation statements)

References 36 publications

Supporting

Mentioning

210

Contrasting

Unclassified

Order By: Relevance

“…The liver performs a wide range of biological functions in metabolic and immunological homeostasis, and contributes to bacterial clearance in sepsis [4]. It has been demonstrated that liver failure is significantly associated with poor prognosis in critically ill sepsis patients [5].…”

Section: Introductionmentioning

confidence: 99%

Attenuation of sepsis-induced rat liver injury by epigallocatechin gallate via suppression of oxidative stress-related inflammation

Yang¹,

Li²,

Shi³

2018

Trop. J. Pharm Res

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Attenuation of sepsis-induced rat liver injury by epigallocatechin gallate via suppression of oxidative stress-related inflammation

Yang¹,

Li²,

Shi³

2018

Trop. J. Pharm Res

View full text Add to dashboard Cite

show abstract

“…While much attention has rightly been directed towards the development of predictive models which seek to measure illness severity and forecast outcome in severe multiple organ failure [1], severe respiratory failure [2] and renal injury [3], less work has been undertaken to elucidate the specific impact of acute hepatic dysfunction in the context of chronic liver disease-despite recognition that liver injury in critically ill patients is associated with poor outcome [4]. The complex care needs and high mortality of patients with severe acute liver failure is well-described [5], and approaches for predicting outcomes for patients with chronic liver disease [6], decompensated cirrhosis [7] and cirrhotic patients in the intensive care unit (ICU) [8] are established.…”

mentioning

confidence: 99%

Is LiFe worth living? It all depends on the liver

Warrillow

Herrera-Gutiérrez

2016

Intensive Care Med

View full text Add to dashboard Cite

Regardless of the initial cause, critical illness almost invariably involves serious derangement of function across multiple organs and body systems. While much attention has rightly been directed towards the development of predictive models which seek to measure illness severity and forecast outcome in severe multiple organ failure [1], severe respiratory failure [2] and renal injury [3], less work has been undertaken to elucidate the specific impact of acute hepatic dysfunction in the context of chronic liver disease-despite recognition that liver injury in critically ill patients is associated with poor outcome [4]. The complex care needs and high mortality of patients with severe acute liver failure is well-described [5], and approaches for predicting outcomes for patients with chronic liver disease [6], decompensated cirrhosis [7] and cirrhotic patients in the intensive care unit (ICU) [8] are established. Regardless of these advances, however, the importance of evolving hepatic dysfunction as part of an overall non-liver specific critical illness may still be underappreciated [9], even in patients with known chronic liver problems. In their work to develop a laboratory-based liver injury failure evaluation (LiFe) score, Edmark et al. [10] outline an interesting approach to the development, validation and potential application of a simple tool that may assist intensivists in the evaluation and management of patients with known chronic liver disease admitted to the ICU.In developing the LiFe score, Edmark and colleagues first conducted an online survey of European Society of Intensive Care Medicine members and received over 150 responses, mainly from European clinicians. Over onethird of respondents indicated that they worked in academic centers with specific hepatobiliary expertise. From the survey results, the three most highly ranked markers of liver injury were identified: the international normalised ratio (INR), total bilirubin and arterial lactate-considered to be representative of liver synthetic capacity, excretory function and metabolic properties, respectively. A research registry holding records from two large academic medical centres in Boston was then accessed to obtain de-identified records of patients admitted to the ICU during an 18-year period ending in 2007. Over 90,000 records were evaluated, of which more than 85,000 were excluded from the analysis because the patients did not have chronic liver disease and more than 6000 were excluded because laboratory test results for the three aforementioned parameters were not available. The Boston-based derivation cohort was therefore ultimately based on 945 patients. Records from a major liver transplant centre in London were then accessed to obtain the validation cohort of 971 patients. A clinical prediction tool was then created using a logistic regression model describing the risk of 30-day mortality as a function of lactate, INR and total bilirubin data collected from the derivation cohort at admission to ICU. Further statistical refinement an...

show abstract

“…However, alterations in biochemical liver function tests are commonly observed in critically ill patients, and interpreted as signs of hepato-biliary dysfunction and cholestasis [2][3][4]. Two pathophysiological conditions are typically distinguished based on laboratory parameters and clinical presentation: "hypoxic hepatitis" and "cholestatic liver dysfunction" [5].…”

Section: Introductionmentioning

confidence: 99%

“…Two pathophysiological conditions are typically distinguished based on laboratory parameters and clinical presentation: "hypoxic hepatitis" and "cholestatic liver dysfunction" [5]. Both conditions are associated with increased morbidity, mortality and a longer hospital length of stay [2,[6][7][8].…”

Section: Introductionmentioning

confidence: 99%

Cholestatic liver (dys)function during sepsis and other critical illnesses

et al. 2015

View full text Add to dashboard Cite

Abstract:Objective: In ICU patients, abnormal liver tests are common. Markers of cholestasis are associated with adverse outcome. Research has focused on the possibility that mild hyperbilirubinemia, instead of indicating inadvertent cholestasis, may be adaptive and beneficial. These new insights are reviewed and integrated in the state-of-the-art knowledge on hepato-biliary alterations during sepsis and other critical illnesses.Data Sources: Relevant publications were searched in Medline with search terms bile, bile acids, cholestasis, critical illness, intensive care, sepsis, alone or in combination.

show abstract

Incidence and prognosis of early hepatic dysfunction in critically ill patients—A prospective multicenter study

Cited by 263 publications

References 36 publications

Attenuation of sepsis-induced rat liver injury by epigallocatechin gallate via suppression of oxidative stress-related inflammation

Attenuation of sepsis-induced rat liver injury by epigallocatechin gallate via suppression of oxidative stress-related inflammation

Is LiFe worth living? It all depends on the liver

Cholestatic liver (dys)function during sepsis and other critical illnesses

Contact Info

Product

Resources

About